|
CEO
Spotlight: Codon Devices’ John P. Danner on Constructive
Biology™
By Laurie Sullivan, May 24, 2007
John
P. Danner, president and CEO of Codon Devices, Inc., describes
his company's work in an interview. "Codon Devices is
focused on enabling commercial applications of synthetic
biology. Our proprietary synthesis and design technologies
are contributing to a paradigm shift that we call
Constructive Biology, which we really view as the next
major wave of innovation in biotechnology," says
Danner. Read
More
Functional
Assays Take HTS in New Directions
By Vicki Glaser, March 22, 2007
Novel approaches to conducting biochemical, functional,
and ADME-tox assays in high-throughput formats are
generating lead compounds that come with a substantial
"resume" profiling their activity, specificity,
and pharmacokinetic and pharmacodynamic characteristics. Read
More
Breathing
New Life into Structure-Based Design
By Vicki Glaser, March 15, 2007
Current approaches to structure-based design are better
than traditional methods because there is a lot more
information available (e.g., better physicochemical and
pathway information and a broader range of assay data) to
guide small-molecule design strategies. Read
More
|
